financetom
Business
financetom
/
Business
/
Hims & Hers Health Insider Sold Shares Worth $483,965, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hims & Hers Health Insider Sold Shares Worth $483,965, According to a Recent SEC Filing
Dec 27, 2024 2:12 PM

04:52 PM EST, 12/27/2024 (MT Newswires) -- Michael Chi, Chief Commercial Officer, on December 24, 2024, sold 17,303 shares in Hims & Hers Health ( HIMS ) for $483,965. Following the Form 4 filing with the SEC, Chi has control over a total of 193,601 shares of the company, with 193,601 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1773751/000177375124000410/xslF345X05/wk-form4_1735336063.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CVS Health EPS Estimates Lowered Amid Rising Costs, Medical Loss Ratio Concerns, UBS Says
CVS Health EPS Estimates Lowered Amid Rising Costs, Medical Loss Ratio Concerns, UBS Says
Oct 22, 2024
04:22 PM EDT, 10/22/2024 (MT Newswires) -- CVS Health's ( CVS ) Q3, full-year 2024 and 2025 earnings per share forecasts have been lowered due to rising costs, elevated medical loss ratio and uncertainties surrounding its Medicare Advantage plans, UBS Securities said in a report emailed Tuesday. UBS discusses the uncertainty surrounding CVS's financial outlook, and how much of the...
Meta Platforms defeats shareholder lawsuit over child safety claims
Meta Platforms defeats shareholder lawsuit over child safety claims
Oct 22, 2024
(Reuters) - Meta Platforms ( META ) and Chief Executive Mark Zuckerberg won the dismissal of a lawsuit claiming they misled shareholders in Meta's proxy statement about their ability to ensure the safety of children who use Facebook and Instagram. In a decision on Tuesday, U.S. District Judge Charles Breyer in San Francisco said the plaintiff Matt Eisner failed to...
Vaxcyte Insider Sold Shares Worth $4,846,508, According to a Recent SEC Filing
Vaxcyte Insider Sold Shares Worth $4,846,508, According to a Recent SEC Filing
Oct 22, 2024
04:21 PM EDT, 10/22/2024 (MT Newswires) -- Andrew Guggenhime, President and CFO, on October 18, 2024, sold 42,000 shares in Vaxcyte ( PCVX ) for $4,846,508. Following the Form 4 filing with the SEC, Guggenhime has control over a total of 90,383 shares of the company, with 90,383 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1649094/000164909424000082/xslF345X05/wk-form4_1729627909.xml ...
Texas Instruments Q3 EPS, Revenue Fall; Q4 Outlook Issued
Texas Instruments Q3 EPS, Revenue Fall; Q4 Outlook Issued
Oct 22, 2024
04:23 PM EDT, 10/22/2024 (MT Newswires) -- Texas Instruments ( TXN ) reported Q3 earnings late Tuesday of $1.47 per diluted share, down from $1.85 a year earlier. Analysts polled by Capital IQ expected $1.37. Revenue in the three months ended Sept. 30 fell to $4.15 billion from $4.53 billion a year earlier. Analysts surveyed by Capital IQ expected $4.12...
Copyright 2023-2026 - www.financetom.com All Rights Reserved